Current Cancer Drug Targets
Title:Meet the Editorial Board:
Volume: 15 Issue: 2
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Meet the Editorial Board:, Current Cancer Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/156800961502150320094324
DOI https://dx.doi.org/10.2174/156800961502150320094324 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
19
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cyclooxygenase-2 Inhibition and Gastric Cancer
Current Pharmaceutical Design Antimicrobial Cyanopeptide Action on Bacterial Cells Observed with Atomic Force Microscopy
Current Nanoscience Combined Effect of Anti-Angiogentic Agents, Angiotensin Type 1 Receptor Antagonists and Radiation Therapy
Current Signal Transduction Therapy Toxicity of Ionic Liquids Towards Mammalian Cell Lines
Current Organic Chemistry Gene Therapy (Part I)
Current Gene Therapy Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Current Cancer Drug Targets Selective Matrix Metalloproteinase Inhibitors for Cancer
Current Medicinal Chemistry Inhibitory Effect on Replicative DNA Polymerases, Human Cancer Cell Proliferation, and In Vivo Anti-Tumor Activity by Glycolipids from Spinach
Current Medicinal Chemistry Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer
Current Cancer Drug Targets MicroRNAs as Critical Regulators Involved in Regulating Epithelial- Mesenchymal Transition
Current Cancer Drug Targets A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon
Anti-Cancer Agents in Medicinal Chemistry Roles of miRNA in the Initiation and Development of Colorectal Carcinoma
Current Pharmaceutical Design Heparanase Patents: Dim Past and Bright Future
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy
Current Molecular Pharmacology Regulation of KRAS-PAK4 Axis by MicroRNAs in Cancer
Current Pharmaceutical Design Genetic Instability Influences Drug Response in Cancer Cells
Current Drug Targets Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes
Current Drug Targets New Insights in Mast Cell Modulation by Palmitoylethanolamide
CNS & Neurological Disorders - Drug Targets Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience Role of Glucocorticoids in Breast Cancer
Current Pharmaceutical Design